Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Postoperative IMRT with lobaplatin versus cisplatin for early cervical cancer
ChiCTR1800018249Phase 2Recruiting
- Sponsor
- Affiliated Hospital of Southwest Medical University
- Start
- Jul 2018
- Modality
- Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of lobaplatin and cisplatin in Cervical Cancer (CC) (2 arms), sponsored by Affiliated Hospital of Southwest Medical University. Primary endpoints: Disease-free progression survival, Overall survival and 1 more. Started Jul 2018; status: recruiting.
02
Drugs
lobaplatincisplatin
03
Conditions
Cervical Cancer (CC)
Beyond the preview
Go deeper on ChiCTR1800018249.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800018249.